Fri, Apr 18, 2014, 6:12 AM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation (GERN) Message Board

  • blackmarango blackmarango Mar 10, 2006 4:21 PM Flag

    For the Board

    If all the data is so promising, why isn't GERON starting human trials in China where they don't have the equivalent of a FDA?

    Been a long while since we have heard anything from GERON's Chinese partner!! Hummmmmmmm?????

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Subj: For the Board
      By: blackmarango
      Date: 03/10/06 04:21 pm

      If all the data is so promising, why isn't GERON starting human trials in China where they don't have the equivalent of a FDA?

      -------------

      Great idea. There's billions of those chinks, perfect for human guinea pigs, right!?! That's what you were thinking, isn't it, RACIST?

      And what's with "black marango"? More of your supremist ideology, I bet. Get lost RR-er.

    • Because of several reasons:

      1) They're a California biotech company. It's easier to say: why aren't you in China doing this, than to actually do it.

      2) China IS NOT easy to operate in. You don't just plunk down $20m and set up shop. China is not a free market, there are a lot of costs to doing business in China, bribes to be paid, officials to deal with, local competitors to watch (intellectual property theft is the biggest threat in China for someone like Geron).

      3) By the time they were to set up shop in China, staff their labs & offices, start trials (while avoiding not killing people, because lawsuits can happen in China just as easily as the US), ramp up to handle actual treatment programs ... they'd damn near be done and approved in the US, say 30 to 36 months from now. And the US is the world's largest and wealthiest market, what approval in the US means is obvious globally.

 
GERN
1.94-0.03(-1.52%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
KeyCorp.
NYSEThu, Apr 17, 2014 4:01 PM EDT
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST